Anticancer Drugs Top Market Review and Current Demand - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2025
Press
Release - 02 Feb 2018 Global Research and Development News
--
.
.
Report
Description-
'
'
Global
Anticancer drugs Market: Scope and Research Methodology
This report on the global anticancer drugs market
analyzes the current and future prospects of the market. The report
comprises an elaborate executive summary, including a market snapshot
that provides overall information of various segments and
sub-segments.
'
'
The
research is a combination of primary and secondary research. Primary
research formed the bulk of our research efforts along with
information collected from telephonic interviews and interactions via
e-mails. Secondary research involved study of company websites,
annual reports, press releases, stock analysis presentations, and
various international and national databases. The report provides
market size in terms of US$ Mn for each segment and sub-segment for
the period from 2017 to 2025, considering the macro and micro
environmental factors. Growth rates for each segment within the
global anticancer drugs market have been determined after a thorough
analysis of past trends, demographics, future trends, technological
developments, and regulatory requirements.
A detailed qualitative analysis of factors
responsible for driving and restraining market growth and future
opportunities has been provided in the market overview section. This
section of the report also includes market attractiveness analysis
that provides a thorough analysis of the overall competitive scenario
in the global anticancer drugs market.
Market revenue in terms of US$ Mn for the period
between 2015 and 2025 along with the compound annual growth rate
(CAGR %) from 2017 to 2025 are provided for all the segments,
considering 2016 as the base year. Market size estimations involved
in-depth study of features of different type of drugs, therapies and
cancer types. Additionally, market related factors such as rise in
preference of targeted therapies, high prevalence rate of cancer,
rise in per capita healthcare expenditure etc. in various geographies
and historical year-on-year growth have been taken into consideration
while estimating the market size.
Anticancer drugs Market: Segmentation
Cancer is caused due to abnormal growth of the
cells. Anticancer drugs are also known as antineoplastic drugs. These
drugs prevents and inhibits the growth of cancer cells.
Based on drug types, global anticancer drugs
market is segmented into cytotoxic drugs, targeted drugs, and
hormonal drugs. The targeted drugs segment is further segmented into
monoclonal antibodies, tyrosine kinase inhibitors and others. The
segment is anticipated to hold a significant share of the global
market. The targeted drugs have a significant demand and is expected
to continue dominating the global market throughout the forecast
period.
Based on therapy type, global anticancer drugs
market is segmented into chemotherapy, targeted therapy,
immunotherapy and others. Targeted therapy held the highest share of
the market and is anticipated to dominate the market during the
forecast period. Side effects of chemotherapy and specificity of the
targeted drug are the factors driving the growth of global market.
Based on cancer types, the global anticancer drugs
market is segmented into lung cancer, breast cancer, leukemia,
colorectal cancer and others. The lung cancer segment is expected to
expand at the fast rate due to high prevalence of the disease
worldwide.
Anticancer drugs Market: Geographical and
Competitive Dynamics
Geographically, the global anticancer drugs market
has been segmented into five regions: North America, Europe, Asia
Pacific, Latin America and Middle East & Africa. In addition, the
regions have been further segmented by major countries from each
region.
The report also profiles major players in the
anticancer drugs market based on various attributes such as company
overview, financial overview, SWOT analysis, key business strategies,
product portfolio, and recent developments. Key companies profiled in
the report include F. Hoffmann-La Roche Ltd, Eli Lilly and Company,
CELGENE CORPORATION, Novartis AG, Pfizer Inc, Amgen Inc, Bayer AG,
AstraZeneca, Takeda Pharmaceutical Company Limited, Merck & Co.,
Inc. etc.
The global anticancer drugs market has been
segmented as follows:
Global Anticancer drugs Market, by Drug
Type
- Cytotoxic Drugs
- Alkylating Agents
- Antimetabolites
- Others
- Targeted Drugs
- Monoclonal Antibodies
- Tyrosine Kinase Inhibitors
- Others
- Hormonal Drugs
Global Anticancer drugs Market, by Therapy
Type
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Others
Global Anticancer drugs Market, by Cancer
Type
- Lung Cancer
- Breast Cancer
- Leukemia
- Colorectal Cancer
- Others
Global Anticancer Drugs Market, by
Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia & NZ
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Rest of LATAM
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of MEA
.
.
– More
Clear Details get Table of Contents
https://www.researchmoz.us/anticancer-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2025-report.html/toc
Comments
Post a Comment